Doris Barcellona/Fondazione Arianna Anticoagulazione
Aug 22, 2025, 03:37
Lupus Anticoagulant-Hypoprothrombinemia Syndrome: Review by Doris Barcellona and Colleagues
Maria Filomena Ruberto, Biologist specialized in Clinical Pathology and Clinical Biochemistry and II Level Master’s degree in Hemostasis and Thrombosis, shared on LinkedIn:
”Doris Barcellona et al.Lupus Anticoagulant-hypoprothrombinemia Syndrome: A Review Enriched by a New Particular Patient. Semin Thromb Hemost. 2025.”
Read the full article here.
Article: Lupus Anticoagulant-hypoprothrombinemia Syndrome: A Review Enriched by a New Particular Patient
Authors: Doris Barcellona , Antonella Mameli , Roberta Montisci , Maria Filomena Ruberto , Lara Fenu , Francesco Marongiu
Stay updated on all scientific advances in the field of bleeding disorders with Hemostasis Today.
-
Jul 2, 2026, 15:59Raul Santos: Why Does LDL-C Remain Elevated in Many Patients?
-
Jul 2, 2026, 15:16Tim Patel: How Regular Movement Helps Keep Blood Flowing Throughout the Day
-
Jul 2, 2026, 13:16Nathan Connell: Is It Time to Rethink What We Tell Hemophilia B Carriers About Pregnancy?
-
Jul 2, 2026, 13:09Bruce Ovbiagele: WSO SCDKIDS Task Force’s Webinar Sheds Light On Care of Sickle Cell Disease-Related Stroke
-
Jul 2, 2026, 12:55Taraneh G. Farazi: The Latest Stroke Clinician Issue Highlights the Importance of Patient Voices in Dysphagia Care
-
Jul 2, 2026, 12:45Kaveh Mehrvar: The Gut–Brain Axis May Hold New Clues to Stroke Pathophysiology
-
Jul 2, 2026, 12:28Expanding Stroke Education Through Mobile Stroke Clinics – Ethiopia Stroke Foundation
-
Jul 2, 2026, 11:52Praveen Kumar Tirlangi: A New Mechanism of Bleeding in Kyasanur Forest Disease
-
Jul 2, 2026, 11:17Heghine Khachatryan: Novel Biomarkers for Cancer-Associated Thrombosis